Director
Spirovant Sciences, Inc.
Philadelphia, Pennsylvania, United States
Lillian Falese is the Director of Bioanalytical Development at Spirovant Sciences, overseeing assay strategy, technical method development/validation as well as the development and implementation of biomarker strategies to support non-clinical and clinical programs in Spirovant’s inhalation gene therapy pipeline. In addition to in-house technology development and significant outsourcing partnerships, Lillian is responsible for clinical operational oversight related to sample collection, management and analysis. She has a decade of industry experience, all in the bioanalytical support of gene therapy programs. Prior to joining Spirovant Sciences in 2021, she held positions with Sangamo Therapeutics and BioMarin Pharmaceutical, providing bioanalytical support for their cell and gene therapy development programs. Lillian earned her M.S. in Biology from Villanova university and B.A. in Biology from the University of Pennsylvania.
Disclosure information not submitted.
Monday, April 24, 2023
2:30 PM – 3:15 PM ET